Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: A prospective cohort study

OncoTargets and Therapy

Volumn 7, Issue , 2014, Pages 485-490

  Greenspoon, Jeffrey Noah ^a   Sharieff, Waseem ^a   Hirte, Holger ^a   Overholt, Andrew ^a   Devillers, Rocco ^a   Gunnarsson, Thorsteinn ^a   Whitton, Anthony ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Anti angiogenic therapy; Brain tumor; GBM; Re treatment

Indexed keywords

STEROID; TEMOZOLOMIDE;

ACUTE TOXICITY; ADULT; AGED; ANTIANGIOGENIC THERAPY; ARTICLE; BRAIN NECROSIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; GLIOBLASTOMA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; ROBOTICS; SALVAGE THERAPY; STEREOTACTIC RADIOSURGERY; TUMOR VOLUME; UNSPECIFIED SIDE EFFECT;

EID: 84897125848     PISSN: 11786930     EISSN: None     Source Type: Journal    
DOI: 10.2147/OTT.S60358     Document Type: Article

References (20)

1. Easaw JC, Mason WP, Perry J, et al. Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme. Curr Oncol. 2011;18:e123-e136.
2. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concominant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987-996.
3. Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concominant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized Phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459-466.
4. Hegi M, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352: 997-1003.
5. Fukushima T, Takeshima H, Kataoka H. Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT. Anticancer Res. 2009;29:4845-4854.
6. Minniti G, Amelio D, Amichetti M, et al. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Radiother Oncol. 2010;97:337-381.
7. Mayer R, Sminia P. Reirradiation tolerance of the human brain. Int J Radiation Oncology Biol Phys. 2008;70:1350-1360.
8. Skeie BS, Enger PO, Brogger J, et al. Gamma knife surgery versus reoperation for recurrent glioblastoma multiforme. World Neurosurg. 2012;78:658-669.
9. Jaeckle KA, Hess KR, Yung WKA, et al. Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American brain tumor consortium study. J Clin Oncol. 2003;21:2305-2311.
10. Brandes AA, Tosoni A, Cavallo G, et al. Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from the gruppo italioano cooperative di neuro-oncologia (GICNO). Br J Cancer. 2006;95:1155-1160.
11. Friedman HS, Prados MD, Wen PY, et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2009;27:4733-4740.
12. Perry JR, Belanger K, Mason WP, et al. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study. J Clin Oncol. 2010;28:2051-2057.
13. Combs SE, Thimann C, Edler L, Debus J, Schulz-Ertner D. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. J Clin Oncol. 2005;23:8863-8869.
14. Fogh SE, Andrews DW, Glass J, et al. Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. J Clin Oncol. 2010;28:3048-3053.
15. Conti A, Pontoriero A, Donatella A, et al. Efficacy and toxicity of CyberKnife re-irradiation and "dose dense" temozolomide for recurrent gliomas. Acta Neurochir. 2012;154:203-209.
16. Combs SE, Bischof M, Welzel T, et al. Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas. J Neurooncol. 2008;89:205-210.
17. Park KJ, Kano H, Iyer A, et al. Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case-control study. J Neurooncol. 2012;107:323-333.
18. Romanelli P, Conti A, Pontoriero A, et al. Rose of stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of recurrent glioblastoma multiforme. Neurosurg Focus. 2009;27(6):E8.
19. Macdonald DR, Cascino TL, Schold SC, Cairncross JG. Response criteria for Phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990;8:1277-1280.
20. Hall EJ, Giaccia AJ. Radiobiology for the Radiologist. Lippincott Williams & Wilkins, Philadelphia; 2006.